Global Drug-Device Combination Products Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
LPI (LP Information)' newest research report, the “Drug-Device Combination Products Industry Forecast” looks at past sales and reviews total world Drug-Device Combination Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug-Device Combination Products sales for 2023 through 2029. With Drug-Device Combination Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-Device Combination Products industry.
This Insight Report provides a comprehensive analysis of the global Drug-Device Combination Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-Device Combination Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug-Device Combination Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-Device Combination Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-Device Combination Products.
The global Drug-Device Combination Products market size is projected to grow from US$ 34430 million in 2022 to US$ 50080 million in 2029; it is expected to grow at a CAGR of 50080 from 2023 to 2029.
Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific.
In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Device Combination Products market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Drug-Device Combination Products market?
What factors are driving Drug-Device Combination Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug-Device Combination Products market opportunities vary by end market size?
How does Drug-Device Combination Products break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
LPI (LP Information)' newest research report, the “Drug-Device Combination Products Industry Forecast” looks at past sales and reviews total world Drug-Device Combination Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug-Device Combination Products sales for 2023 through 2029. With Drug-Device Combination Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-Device Combination Products industry.
This Insight Report provides a comprehensive analysis of the global Drug-Device Combination Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-Device Combination Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug-Device Combination Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-Device Combination Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-Device Combination Products.
The global Drug-Device Combination Products market size is projected to grow from US$ 34430 million in 2022 to US$ 50080 million in 2029; it is expected to grow at a CAGR of 50080 from 2023 to 2029.
Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific.
In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Device Combination Products market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Drug-Coated Device
- Prefilled Drug Delivery Systems
- Others
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Polyzen
- Kaleo
- Terumo Corporation
- Nuventra
- Antares
- Novus Therapeutics
What is the 10-year outlook for the global Drug-Device Combination Products market?
What factors are driving Drug-Device Combination Products market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Drug-Device Combination Products market opportunities vary by end market size?
How does Drug-Device Combination Products break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug-Device Combination Products Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug-Device Combination Products by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug-Device Combination Products by Country/Region, 2018, 2022 & 2029
2.2 Drug-Device Combination Products Segment by Type
2.2.1 Drug-Coated Device
2.2.2 Prefilled Drug Delivery Systems
2.2.3 Others
2.3 Drug-Device Combination Products Sales by Type
2.3.1 Global Drug-Device Combination Products Sales Market Share by Type (2018-2023)
2.3.2 Global Drug-Device Combination Products Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug-Device Combination Products Sale Price by Type (2018-2023)
2.4 Drug-Device Combination Products Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Drug-Device Combination Products Sales by Application
2.5.1 Global Drug-Device Combination Products Sale Market Share by Application (2018-2023)
2.5.2 Global Drug-Device Combination Products Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug-Device Combination Products Sale Price by Application (2018-2023)
3 GLOBAL DRUG-DEVICE COMBINATION PRODUCTS BY COMPANY
3.1 Global Drug-Device Combination Products Breakdown Data by Company
3.1.1 Global Drug-Device Combination Products Annual Sales by Company (2018-2023)
3.1.2 Global Drug-Device Combination Products Sales Market Share by Company (2018-2023)
3.2 Global Drug-Device Combination Products Annual Revenue by Company (2018-2023)
3.2.1 Global Drug-Device Combination Products Revenue by Company (2018-2023)
3.2.2 Global Drug-Device Combination Products Revenue Market Share by Company (2018-2023)
3.3 Global Drug-Device Combination Products Sale Price by Company
3.4 Key Manufacturers Drug-Device Combination Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Device Combination Products Product Location Distribution
3.4.2 Players Drug-Device Combination Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG-DEVICE COMBINATION PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic Drug-Device Combination Products Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug-Device Combination Products Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug-Device Combination Products Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug-Device Combination Products Market Size by Country/Region (2018-2023)
4.2.1 Global Drug-Device Combination Products Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug-Device Combination Products Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug-Device Combination Products Sales Growth
4.4 APAC Drug-Device Combination Products Sales Growth
4.5 Europe Drug-Device Combination Products Sales Growth
4.6 Middle East & Africa Drug-Device Combination Products Sales Growth
5 AMERICAS
5.1 Americas Drug-Device Combination Products Sales by Country
5.1.1 Americas Drug-Device Combination Products Sales by Country (2018-2023)
5.1.2 Americas Drug-Device Combination Products Revenue by Country (2018-2023)
5.2 Americas Drug-Device Combination Products Sales by Type
5.3 Americas Drug-Device Combination Products Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Device Combination Products Sales by Region
6.1.1 APAC Drug-Device Combination Products Sales by Region (2018-2023)
6.1.2 APAC Drug-Device Combination Products Revenue by Region (2018-2023)
6.2 APAC Drug-Device Combination Products Sales by Type
6.3 APAC Drug-Device Combination Products Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug-Device Combination Products by Country
7.1.1 Europe Drug-Device Combination Products Sales by Country (2018-2023)
7.1.2 Europe Drug-Device Combination Products Revenue by Country (2018-2023)
7.2 Europe Drug-Device Combination Products Sales by Type
7.3 Europe Drug-Device Combination Products Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug-Device Combination Products by Country
8.1.1 Middle East & Africa Drug-Device Combination Products Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug-Device Combination Products Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug-Device Combination Products Sales by Type
8.3 Middle East & Africa Drug-Device Combination Products Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-Device Combination Products
10.3 Manufacturing Process Analysis of Drug-Device Combination Products
10.4 Industry Chain Structure of Drug-Device Combination Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-Device Combination Products Distributors
11.3 Drug-Device Combination Products Customer
12 WORLD FORECAST REVIEW FOR DRUG-DEVICE COMBINATION PRODUCTS BY GEOGRAPHIC REGION
12.1 Global Drug-Device Combination Products Market Size Forecast by Region
12.1.1 Global Drug-Device Combination Products Forecast by Region (2024-2029)
12.1.2 Global Drug-Device Combination Products Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug-Device Combination Products Forecast by Type
12.7 Global Drug-Device Combination Products Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Polyzen
13.1.1 Polyzen Company Information
13.1.2 Polyzen Drug-Device Combination Products Product Portfolios and Specifications
13.1.3 Polyzen Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Polyzen Main Business Overview
13.1.5 Polyzen Latest Developments
13.2 Kaleo
13.2.1 Kaleo Company Information
13.2.2 Kaleo Drug-Device Combination Products Product Portfolios and Specifications
13.2.3 Kaleo Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Kaleo Main Business Overview
13.2.5 Kaleo Latest Developments
13.3 Terumo Corporation
13.3.1 Terumo Corporation Company Information
13.3.2 Terumo Corporation Drug-Device Combination Products Product Portfolios and Specifications
13.3.3 Terumo Corporation Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Terumo Corporation Main Business Overview
13.3.5 Terumo Corporation Latest Developments
13.4 Nuventra
13.4.1 Nuventra Company Information
13.4.2 Nuventra Drug-Device Combination Products Product Portfolios and Specifications
13.4.3 Nuventra Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Nuventra Main Business Overview
13.4.5 Nuventra Latest Developments
13.5 Antares
13.5.1 Antares Company Information
13.5.2 Antares Drug-Device Combination Products Product Portfolios and Specifications
13.5.3 Antares Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Antares Main Business Overview
13.5.5 Antares Latest Developments
13.6 Novus Therapeutics
13.6.1 Novus Therapeutics Company Information
13.6.2 Novus Therapeutics Drug-Device Combination Products Product Portfolios and Specifications
13.6.3 Novus Therapeutics Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novus Therapeutics Main Business Overview
13.6.5 Novus Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug-Device Combination Products Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Drug-Device Combination Products by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Drug-Device Combination Products by Country/Region, 2018, 2022 & 2029
2.2 Drug-Device Combination Products Segment by Type
2.2.1 Drug-Coated Device
2.2.2 Prefilled Drug Delivery Systems
2.2.3 Others
2.3 Drug-Device Combination Products Sales by Type
2.3.1 Global Drug-Device Combination Products Sales Market Share by Type (2018-2023)
2.3.2 Global Drug-Device Combination Products Revenue and Market Share by Type (2018-2023)
2.3.3 Global Drug-Device Combination Products Sale Price by Type (2018-2023)
2.4 Drug-Device Combination Products Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Drug-Device Combination Products Sales by Application
2.5.1 Global Drug-Device Combination Products Sale Market Share by Application (2018-2023)
2.5.2 Global Drug-Device Combination Products Revenue and Market Share by Application (2018-2023)
2.5.3 Global Drug-Device Combination Products Sale Price by Application (2018-2023)
3 GLOBAL DRUG-DEVICE COMBINATION PRODUCTS BY COMPANY
3.1 Global Drug-Device Combination Products Breakdown Data by Company
3.1.1 Global Drug-Device Combination Products Annual Sales by Company (2018-2023)
3.1.2 Global Drug-Device Combination Products Sales Market Share by Company (2018-2023)
3.2 Global Drug-Device Combination Products Annual Revenue by Company (2018-2023)
3.2.1 Global Drug-Device Combination Products Revenue by Company (2018-2023)
3.2.2 Global Drug-Device Combination Products Revenue Market Share by Company (2018-2023)
3.3 Global Drug-Device Combination Products Sale Price by Company
3.4 Key Manufacturers Drug-Device Combination Products Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug-Device Combination Products Product Location Distribution
3.4.2 Players Drug-Device Combination Products Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR DRUG-DEVICE COMBINATION PRODUCTS BY GEOGRAPHIC REGION
4.1 World Historic Drug-Device Combination Products Market Size by Geographic Region (2018-2023)
4.1.1 Global Drug-Device Combination Products Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Drug-Device Combination Products Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Drug-Device Combination Products Market Size by Country/Region (2018-2023)
4.2.1 Global Drug-Device Combination Products Annual Sales by Country/Region (2018-2023)
4.2.2 Global Drug-Device Combination Products Annual Revenue by Country/Region (2018-2023)
4.3 Americas Drug-Device Combination Products Sales Growth
4.4 APAC Drug-Device Combination Products Sales Growth
4.5 Europe Drug-Device Combination Products Sales Growth
4.6 Middle East & Africa Drug-Device Combination Products Sales Growth
5 AMERICAS
5.1 Americas Drug-Device Combination Products Sales by Country
5.1.1 Americas Drug-Device Combination Products Sales by Country (2018-2023)
5.1.2 Americas Drug-Device Combination Products Revenue by Country (2018-2023)
5.2 Americas Drug-Device Combination Products Sales by Type
5.3 Americas Drug-Device Combination Products Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Device Combination Products Sales by Region
6.1.1 APAC Drug-Device Combination Products Sales by Region (2018-2023)
6.1.2 APAC Drug-Device Combination Products Revenue by Region (2018-2023)
6.2 APAC Drug-Device Combination Products Sales by Type
6.3 APAC Drug-Device Combination Products Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug-Device Combination Products by Country
7.1.1 Europe Drug-Device Combination Products Sales by Country (2018-2023)
7.1.2 Europe Drug-Device Combination Products Revenue by Country (2018-2023)
7.2 Europe Drug-Device Combination Products Sales by Type
7.3 Europe Drug-Device Combination Products Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug-Device Combination Products by Country
8.1.1 Middle East & Africa Drug-Device Combination Products Sales by Country (2018-2023)
8.1.2 Middle East & Africa Drug-Device Combination Products Revenue by Country (2018-2023)
8.2 Middle East & Africa Drug-Device Combination Products Sales by Type
8.3 Middle East & Africa Drug-Device Combination Products Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug-Device Combination Products
10.3 Manufacturing Process Analysis of Drug-Device Combination Products
10.4 Industry Chain Structure of Drug-Device Combination Products
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug-Device Combination Products Distributors
11.3 Drug-Device Combination Products Customer
12 WORLD FORECAST REVIEW FOR DRUG-DEVICE COMBINATION PRODUCTS BY GEOGRAPHIC REGION
12.1 Global Drug-Device Combination Products Market Size Forecast by Region
12.1.1 Global Drug-Device Combination Products Forecast by Region (2024-2029)
12.1.2 Global Drug-Device Combination Products Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Drug-Device Combination Products Forecast by Type
12.7 Global Drug-Device Combination Products Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Polyzen
13.1.1 Polyzen Company Information
13.1.2 Polyzen Drug-Device Combination Products Product Portfolios and Specifications
13.1.3 Polyzen Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Polyzen Main Business Overview
13.1.5 Polyzen Latest Developments
13.2 Kaleo
13.2.1 Kaleo Company Information
13.2.2 Kaleo Drug-Device Combination Products Product Portfolios and Specifications
13.2.3 Kaleo Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Kaleo Main Business Overview
13.2.5 Kaleo Latest Developments
13.3 Terumo Corporation
13.3.1 Terumo Corporation Company Information
13.3.2 Terumo Corporation Drug-Device Combination Products Product Portfolios and Specifications
13.3.3 Terumo Corporation Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Terumo Corporation Main Business Overview
13.3.5 Terumo Corporation Latest Developments
13.4 Nuventra
13.4.1 Nuventra Company Information
13.4.2 Nuventra Drug-Device Combination Products Product Portfolios and Specifications
13.4.3 Nuventra Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Nuventra Main Business Overview
13.4.5 Nuventra Latest Developments
13.5 Antares
13.5.1 Antares Company Information
13.5.2 Antares Drug-Device Combination Products Product Portfolios and Specifications
13.5.3 Antares Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Antares Main Business Overview
13.5.5 Antares Latest Developments
13.6 Novus Therapeutics
13.6.1 Novus Therapeutics Company Information
13.6.2 Novus Therapeutics Drug-Device Combination Products Product Portfolios and Specifications
13.6.3 Novus Therapeutics Drug-Device Combination Products Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Novus Therapeutics Main Business Overview
13.6.5 Novus Therapeutics Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug-Device Combination Products Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug-Device Combination Products Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Drug-Coated Device
Table 4. Major Players of Prefilled Drug Delivery Systems
Table 5. Major Players of Others
Table 6. Global Drug-Device Combination Products Sales by Type (2018-2023) & (Units)
Table 7. Global Drug-Device Combination Products Sales Market Share by Type (2018-2023)
Table 8. Global Drug-Device Combination Products Revenue by Type (2018-2023) & ($ million)
Table 9. Global Drug-Device Combination Products Revenue Market Share by Type (2018-2023)
Table 10. Global Drug-Device Combination Products Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Drug-Device Combination Products Sales by Application (2018-2023) & (Units)
Table 12. Global Drug-Device Combination Products Sales Market Share by Application (2018-2023)
Table 13. Global Drug-Device Combination Products Revenue by Application (2018-2023)
Table 14. Global Drug-Device Combination Products Revenue Market Share by Application (2018-2023)
Table 15. Global Drug-Device Combination Products Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Drug-Device Combination Products Sales by Company (2018-2023) & (Units)
Table 17. Global Drug-Device Combination Products Sales Market Share by Company (2018-2023)
Table 18. Global Drug-Device Combination Products Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Drug-Device Combination Products Revenue Market Share by Company (2018-2023)
Table 20. Global Drug-Device Combination Products Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Drug-Device Combination Products Producing Area Distribution and Sales Area
Table 22. Players Drug-Device Combination Products Products Offered
Table 23. Drug-Device Combination Products Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Drug-Device Combination Products Sales by Geographic Region (2018-2023) & (Units)
Table 27. Global Drug-Device Combination Products Sales Market Share Geographic Region (2018-2023)
Table 28. Global Drug-Device Combination Products Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Drug-Device Combination Products Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Drug-Device Combination Products Sales by Country/Region (2018-2023) & (Units)
Table 31. Global Drug-Device Combination Products Sales Market Share by Country/Region (2018-2023)
Table 32. Global Drug-Device Combination Products Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Drug-Device Combination Products Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Drug-Device Combination Products Sales by Country (2018-2023) & (Units)
Table 35. Americas Drug-Device Combination Products Sales Market Share by Country (2018-2023)
Table 36. Americas Drug-Device Combination Products Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Drug-Device Combination Products Revenue Market Share by Country (2018-2023)
Table 38. Americas Drug-Device Combination Products Sales by Type (2018-2023) & (Units)
Table 39. Americas Drug-Device Combination Products Sales by Application (2018-2023) & (Units)
Table 40. APAC Drug-Device Combination Products Sales by Region (2018-2023) & (Units)
Table 41. APAC Drug-Device Combination Products Sales Market Share by Region (2018-2023)
Table 42. APAC Drug-Device Combination Products Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Drug-Device Combination Products Revenue Market Share by Region (2018-2023)
Table 44. APAC Drug-Device Combination Products Sales by Type (2018-2023) & (Units)
Table 45. APAC Drug-Device Combination Products Sales by Application (2018-2023) & (Units)
Table 46. Europe Drug-Device Combination Products Sales by Country (2018-2023) & (Units)
Table 47. Europe Drug-Device Combination Products Sales Market Share by Country (2018-2023)
Table 48. Europe Drug-Device Combination Products Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Drug-Device Combination Products Revenue Market Share by Country (2018-2023)
Table 50. Europe Drug-Device Combination Products Sales by Type (2018-2023) & (Units)
Table 51. Europe Drug-Device Combination Products Sales by Application (2018-2023) & (Units)
Table 52. Middle East & Africa Drug-Device Combination Products Sales by Country (2018-2023) & (Units)
Table 53. Middle East & Africa Drug-Device Combination Products Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Drug-Device Combination Products Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Drug-Device Combination Products Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Drug-Device Combination Products Sales by Type (2018-2023) & (Units)
Table 57. Middle East & Africa Drug-Device Combination Products Sales by Application (2018-2023) & (Units)
Table 58. Key Market Drivers & Growth Opportunities of Drug-Device Combination Products
Table 59. Key Market Challenges & Risks of Drug-Device Combination Products
Table 60. Key Industry Trends of Drug-Device Combination Products
Table 61. Drug-Device Combination Products Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Drug-Device Combination Products Distributors List
Table 64. Drug-Device Combination Products Customer List
Table 65. Global Drug-Device Combination Products Sales Forecast by Region (2024-2029) & (Units)
Table 66. Global Drug-Device Combination Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Drug-Device Combination Products Sales Forecast by Country (2024-2029) & (Units)
Table 68. Americas Drug-Device Combination Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Drug-Device Combination Products Sales Forecast by Region (2024-2029) & (Units)
Table 70. APAC Drug-Device Combination Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Drug-Device Combination Products Sales Forecast by Country (2024-2029) & (Units)
Table 72. Europe Drug-Device Combination Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Drug-Device Combination Products Sales Forecast by Country (2024-2029) & (Units)
Table 74. Middle East & Africa Drug-Device Combination Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Drug-Device Combination Products Sales Forecast by Type (2024-2029) & (Units)
Table 76. Global Drug-Device Combination Products Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Drug-Device Combination Products Sales Forecast by Application (2024-2029) & (Units)
Table 78. Global Drug-Device Combination Products Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Polyzen Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 80. Polyzen Drug-Device Combination Products Product Portfolios and Specifications
Table 81. Polyzen Drug-Device Combination Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Polyzen Main Business
Table 83. Polyzen Latest Developments
Table 84. Kaleo Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 85. Kaleo Drug-Device Combination Products Product Portfolios and Specifications
Table 86. Kaleo Drug-Device Combination Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Kaleo Main Business
Table 88. Kaleo Latest Developments
Table 89. Terumo Corporation Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 90. Terumo Corporation Drug-Device Combination Products Product Portfolios and Specifications
Table 91. Terumo Corporation Drug-Device Combination Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Terumo Corporation Main Business
Table 93. Terumo Corporation Latest Developments
Table 94. Nuventra Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 95. Nuventra Drug-Device Combination Products Product Portfolios and Specifications
Table 96. Nuventra Drug-Device Combination Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Nuventra Main Business
Table 98. Nuventra Latest Developments
Table 99. Antares Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 100. Antares Drug-Device Combination Products Product Portfolios and Specifications
Table 101. Antares Drug-Device Combination Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Antares Main Business
Table 103. Antares Latest Developments
Table 104. Novus Therapeutics Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 105. Novus Therapeutics Drug-Device Combination Products Product Portfolios and Specifications
Table 106. Novus Therapeutics Drug-Device Combination Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Novus Therapeutics Main Business
Table 108. Novus Therapeutics Latest Developments
Table 1. Drug-Device Combination Products Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Drug-Device Combination Products Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Drug-Coated Device
Table 4. Major Players of Prefilled Drug Delivery Systems
Table 5. Major Players of Others
Table 6. Global Drug-Device Combination Products Sales by Type (2018-2023) & (Units)
Table 7. Global Drug-Device Combination Products Sales Market Share by Type (2018-2023)
Table 8. Global Drug-Device Combination Products Revenue by Type (2018-2023) & ($ million)
Table 9. Global Drug-Device Combination Products Revenue Market Share by Type (2018-2023)
Table 10. Global Drug-Device Combination Products Sale Price by Type (2018-2023) & (USD/Unit)
Table 11. Global Drug-Device Combination Products Sales by Application (2018-2023) & (Units)
Table 12. Global Drug-Device Combination Products Sales Market Share by Application (2018-2023)
Table 13. Global Drug-Device Combination Products Revenue by Application (2018-2023)
Table 14. Global Drug-Device Combination Products Revenue Market Share by Application (2018-2023)
Table 15. Global Drug-Device Combination Products Sale Price by Application (2018-2023) & (USD/Unit)
Table 16. Global Drug-Device Combination Products Sales by Company (2018-2023) & (Units)
Table 17. Global Drug-Device Combination Products Sales Market Share by Company (2018-2023)
Table 18. Global Drug-Device Combination Products Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Drug-Device Combination Products Revenue Market Share by Company (2018-2023)
Table 20. Global Drug-Device Combination Products Sale Price by Company (2018-2023) & (USD/Unit)
Table 21. Key Manufacturers Drug-Device Combination Products Producing Area Distribution and Sales Area
Table 22. Players Drug-Device Combination Products Products Offered
Table 23. Drug-Device Combination Products Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Drug-Device Combination Products Sales by Geographic Region (2018-2023) & (Units)
Table 27. Global Drug-Device Combination Products Sales Market Share Geographic Region (2018-2023)
Table 28. Global Drug-Device Combination Products Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Drug-Device Combination Products Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Drug-Device Combination Products Sales by Country/Region (2018-2023) & (Units)
Table 31. Global Drug-Device Combination Products Sales Market Share by Country/Region (2018-2023)
Table 32. Global Drug-Device Combination Products Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Drug-Device Combination Products Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Drug-Device Combination Products Sales by Country (2018-2023) & (Units)
Table 35. Americas Drug-Device Combination Products Sales Market Share by Country (2018-2023)
Table 36. Americas Drug-Device Combination Products Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Drug-Device Combination Products Revenue Market Share by Country (2018-2023)
Table 38. Americas Drug-Device Combination Products Sales by Type (2018-2023) & (Units)
Table 39. Americas Drug-Device Combination Products Sales by Application (2018-2023) & (Units)
Table 40. APAC Drug-Device Combination Products Sales by Region (2018-2023) & (Units)
Table 41. APAC Drug-Device Combination Products Sales Market Share by Region (2018-2023)
Table 42. APAC Drug-Device Combination Products Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Drug-Device Combination Products Revenue Market Share by Region (2018-2023)
Table 44. APAC Drug-Device Combination Products Sales by Type (2018-2023) & (Units)
Table 45. APAC Drug-Device Combination Products Sales by Application (2018-2023) & (Units)
Table 46. Europe Drug-Device Combination Products Sales by Country (2018-2023) & (Units)
Table 47. Europe Drug-Device Combination Products Sales Market Share by Country (2018-2023)
Table 48. Europe Drug-Device Combination Products Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Drug-Device Combination Products Revenue Market Share by Country (2018-2023)
Table 50. Europe Drug-Device Combination Products Sales by Type (2018-2023) & (Units)
Table 51. Europe Drug-Device Combination Products Sales by Application (2018-2023) & (Units)
Table 52. Middle East & Africa Drug-Device Combination Products Sales by Country (2018-2023) & (Units)
Table 53. Middle East & Africa Drug-Device Combination Products Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Drug-Device Combination Products Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Drug-Device Combination Products Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Drug-Device Combination Products Sales by Type (2018-2023) & (Units)
Table 57. Middle East & Africa Drug-Device Combination Products Sales by Application (2018-2023) & (Units)
Table 58. Key Market Drivers & Growth Opportunities of Drug-Device Combination Products
Table 59. Key Market Challenges & Risks of Drug-Device Combination Products
Table 60. Key Industry Trends of Drug-Device Combination Products
Table 61. Drug-Device Combination Products Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Drug-Device Combination Products Distributors List
Table 64. Drug-Device Combination Products Customer List
Table 65. Global Drug-Device Combination Products Sales Forecast by Region (2024-2029) & (Units)
Table 66. Global Drug-Device Combination Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Drug-Device Combination Products Sales Forecast by Country (2024-2029) & (Units)
Table 68. Americas Drug-Device Combination Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Drug-Device Combination Products Sales Forecast by Region (2024-2029) & (Units)
Table 70. APAC Drug-Device Combination Products Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Drug-Device Combination Products Sales Forecast by Country (2024-2029) & (Units)
Table 72. Europe Drug-Device Combination Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Drug-Device Combination Products Sales Forecast by Country (2024-2029) & (Units)
Table 74. Middle East & Africa Drug-Device Combination Products Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Drug-Device Combination Products Sales Forecast by Type (2024-2029) & (Units)
Table 76. Global Drug-Device Combination Products Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Drug-Device Combination Products Sales Forecast by Application (2024-2029) & (Units)
Table 78. Global Drug-Device Combination Products Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Polyzen Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 80. Polyzen Drug-Device Combination Products Product Portfolios and Specifications
Table 81. Polyzen Drug-Device Combination Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 82. Polyzen Main Business
Table 83. Polyzen Latest Developments
Table 84. Kaleo Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 85. Kaleo Drug-Device Combination Products Product Portfolios and Specifications
Table 86. Kaleo Drug-Device Combination Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 87. Kaleo Main Business
Table 88. Kaleo Latest Developments
Table 89. Terumo Corporation Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 90. Terumo Corporation Drug-Device Combination Products Product Portfolios and Specifications
Table 91. Terumo Corporation Drug-Device Combination Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 92. Terumo Corporation Main Business
Table 93. Terumo Corporation Latest Developments
Table 94. Nuventra Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 95. Nuventra Drug-Device Combination Products Product Portfolios and Specifications
Table 96. Nuventra Drug-Device Combination Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 97. Nuventra Main Business
Table 98. Nuventra Latest Developments
Table 99. Antares Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 100. Antares Drug-Device Combination Products Product Portfolios and Specifications
Table 101. Antares Drug-Device Combination Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 102. Antares Main Business
Table 103. Antares Latest Developments
Table 104. Novus Therapeutics Basic Information, Drug-Device Combination Products Manufacturing Base, Sales Area and Its Competitors
Table 105. Novus Therapeutics Drug-Device Combination Products Product Portfolios and Specifications
Table 106. Novus Therapeutics Drug-Device Combination Products Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 107. Novus Therapeutics Main Business
Table 108. Novus Therapeutics Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug-Device Combination Products
Figure 2. Drug-Device Combination Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Device Combination Products Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Drug-Device Combination Products Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug-Device Combination Products Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Drug-Coated Device
Figure 10. Product Picture of Prefilled Drug Delivery Systems
Figure 11. Product Picture of Others
Figure 12. Global Drug-Device Combination Products Sales Market Share by Type in 2022
Figure 13. Global Drug-Device Combination Products Revenue Market Share by Type (2018-2023)
Figure 14. Drug-Device Combination Products Consumed in Hospital
Figure 15. Global Drug-Device Combination Products Market: Hospital (2018-2023) & (Units)
Figure 16. Drug-Device Combination Products Consumed in Clinic
Figure 17. Global Drug-Device Combination Products Market: Clinic (2018-2023) & (Units)
Figure 18. Drug-Device Combination Products Consumed in Others
Figure 19. Global Drug-Device Combination Products Market: Others (2018-2023) & (Units)
Figure 20. Global Drug-Device Combination Products Sales Market Share by Application (2022)
Figure 21. Global Drug-Device Combination Products Revenue Market Share by Application in 2022
Figure 22. Drug-Device Combination Products Sales Market by Company in 2022 (Units)
Figure 23. Global Drug-Device Combination Products Sales Market Share by Company in 2022
Figure 24. Drug-Device Combination Products Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Drug-Device Combination Products Revenue Market Share by Company in 2022
Figure 26. Global Drug-Device Combination Products Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Drug-Device Combination Products Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Drug-Device Combination Products Sales 2018-2023 (Units)
Figure 29. Americas Drug-Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 30. APAC Drug-Device Combination Products Sales 2018-2023 (Units)
Figure 31. APAC Drug-Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 32. Europe Drug-Device Combination Products Sales 2018-2023 (Units)
Figure 33. Europe Drug-Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Drug-Device Combination Products Sales 2018-2023 (Units)
Figure 35. Middle East & Africa Drug-Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 36. Americas Drug-Device Combination Products Sales Market Share by Country in 2022
Figure 37. Americas Drug-Device Combination Products Revenue Market Share by Country in 2022
Figure 38. Americas Drug-Device Combination Products Sales Market Share by Type (2018-2023)
Figure 39. Americas Drug-Device Combination Products Sales Market Share by Application (2018-2023)
Figure 40. United States Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Drug-Device Combination Products Sales Market Share by Region in 2022
Figure 45. APAC Drug-Device Combination Products Revenue Market Share by Regions in 2022
Figure 46. APAC Drug-Device Combination Products Sales Market Share by Type (2018-2023)
Figure 47. APAC Drug-Device Combination Products Sales Market Share by Application (2018-2023)
Figure 48. China Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Drug-Device Combination Products Sales Market Share by Country in 2022
Figure 56. Europe Drug-Device Combination Products Revenue Market Share by Country in 2022
Figure 57. Europe Drug-Device Combination Products Sales Market Share by Type (2018-2023)
Figure 58. Europe Drug-Device Combination Products Sales Market Share by Application (2018-2023)
Figure 59. Germany Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Drug-Device Combination Products Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Drug-Device Combination Products Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Drug-Device Combination Products Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Drug-Device Combination Products Sales Market Share by Application (2018-2023)
Figure 68. Egypt Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Drug-Device Combination Products in 2022
Figure 74. Manufacturing Process Analysis of Drug-Device Combination Products
Figure 75. Industry Chain Structure of Drug-Device Combination Products
Figure 76. Channels of Distribution
Figure 77. Global Drug-Device Combination Products Sales Market Forecast by Region (2024-2029)
Figure 78. Global Drug-Device Combination Products Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Drug-Device Combination Products Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Drug-Device Combination Products Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Drug-Device Combination Products Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Drug-Device Combination Products Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Drug-Device Combination Products
Figure 2. Drug-Device Combination Products Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug-Device Combination Products Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Drug-Device Combination Products Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Drug-Device Combination Products Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Drug-Coated Device
Figure 10. Product Picture of Prefilled Drug Delivery Systems
Figure 11. Product Picture of Others
Figure 12. Global Drug-Device Combination Products Sales Market Share by Type in 2022
Figure 13. Global Drug-Device Combination Products Revenue Market Share by Type (2018-2023)
Figure 14. Drug-Device Combination Products Consumed in Hospital
Figure 15. Global Drug-Device Combination Products Market: Hospital (2018-2023) & (Units)
Figure 16. Drug-Device Combination Products Consumed in Clinic
Figure 17. Global Drug-Device Combination Products Market: Clinic (2018-2023) & (Units)
Figure 18. Drug-Device Combination Products Consumed in Others
Figure 19. Global Drug-Device Combination Products Market: Others (2018-2023) & (Units)
Figure 20. Global Drug-Device Combination Products Sales Market Share by Application (2022)
Figure 21. Global Drug-Device Combination Products Revenue Market Share by Application in 2022
Figure 22. Drug-Device Combination Products Sales Market by Company in 2022 (Units)
Figure 23. Global Drug-Device Combination Products Sales Market Share by Company in 2022
Figure 24. Drug-Device Combination Products Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Drug-Device Combination Products Revenue Market Share by Company in 2022
Figure 26. Global Drug-Device Combination Products Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Drug-Device Combination Products Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Drug-Device Combination Products Sales 2018-2023 (Units)
Figure 29. Americas Drug-Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 30. APAC Drug-Device Combination Products Sales 2018-2023 (Units)
Figure 31. APAC Drug-Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 32. Europe Drug-Device Combination Products Sales 2018-2023 (Units)
Figure 33. Europe Drug-Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Drug-Device Combination Products Sales 2018-2023 (Units)
Figure 35. Middle East & Africa Drug-Device Combination Products Revenue 2018-2023 ($ Millions)
Figure 36. Americas Drug-Device Combination Products Sales Market Share by Country in 2022
Figure 37. Americas Drug-Device Combination Products Revenue Market Share by Country in 2022
Figure 38. Americas Drug-Device Combination Products Sales Market Share by Type (2018-2023)
Figure 39. Americas Drug-Device Combination Products Sales Market Share by Application (2018-2023)
Figure 40. United States Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Drug-Device Combination Products Sales Market Share by Region in 2022
Figure 45. APAC Drug-Device Combination Products Revenue Market Share by Regions in 2022
Figure 46. APAC Drug-Device Combination Products Sales Market Share by Type (2018-2023)
Figure 47. APAC Drug-Device Combination Products Sales Market Share by Application (2018-2023)
Figure 48. China Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Drug-Device Combination Products Sales Market Share by Country in 2022
Figure 56. Europe Drug-Device Combination Products Revenue Market Share by Country in 2022
Figure 57. Europe Drug-Device Combination Products Sales Market Share by Type (2018-2023)
Figure 58. Europe Drug-Device Combination Products Sales Market Share by Application (2018-2023)
Figure 59. Germany Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Drug-Device Combination Products Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Drug-Device Combination Products Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Drug-Device Combination Products Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Drug-Device Combination Products Sales Market Share by Application (2018-2023)
Figure 68. Egypt Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Drug-Device Combination Products Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Drug-Device Combination Products in 2022
Figure 74. Manufacturing Process Analysis of Drug-Device Combination Products
Figure 75. Industry Chain Structure of Drug-Device Combination Products
Figure 76. Channels of Distribution
Figure 77. Global Drug-Device Combination Products Sales Market Forecast by Region (2024-2029)
Figure 78. Global Drug-Device Combination Products Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Drug-Device Combination Products Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Drug-Device Combination Products Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Drug-Device Combination Products Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Drug-Device Combination Products Revenue Market Share Forecast by Application (2024-2029)
